Analysis: Still wary of Russian vaccine, Brazil clears its own ‘study’ for more data

Published by
Reuters

By Lisandra Paraguassu BRASILIA (Reuters) – Russian vaccine developers cheered hard-won access to Brazil’s market last week, but with less than a million doses cleared for import, public health experts say the approval is more like a late-stage trial for the Sputnik V shot. Late Friday, Brazilian health regulator Anvisa, which was under pressure from state governors and the country’s Supreme Court, ruled that states could import the Russian COVID-19 vaccine, but included some 20 strict conditions. Those restrictions undercut the impact of the approval and echo a cautious approach to the Russia…

Read More

Share this Story
Load More Related Articles
Load More In US News

Facebook Comments

Check Also

Wales beat Turkey 2-0 despite Bale penalty miss

Published by DPA Wales secured their first win ...

Archives